Trevi Therapeutics
TRVI
TRVI
198 hedge funds and large institutions have $1.61B invested in Trevi Therapeutics in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 62
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
1% less capital invested
Capital invested by funds: $1.63B → $1.61B (-$17M)
Holders
198
Holding in Top 10
9
Calls
$11.1M
Puts
$5.67M
Top Buyers
| 1 | +$24.3M | |
| 2 | +$20M | |
| 3 | +$17.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.7M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$9.92M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$12.5M | |
| 3 | -$8.24M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$6.88M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$6.78M |
